» Articles » PMID: 27191472

Capturing Heterogeneity in Medical Marijuana Policies: A Taxonomy of Regulatory Regimes Across the United States

Overview
Publisher Informa Healthcare
Date 2016 May 19
PMID 27191472
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There is considerable movement in the U.S. to legalize use of cannabis for medicinal purposes. Twenty-three U.S. states and the District of Columbia have laws that decriminalize use of marijuana for medicinal purposes. Most prior studies of state medical marijuana laws and their association with overall marijuana use, adolescent use, crime rates, and alcohol traffic fatalities have used a binary coding of whether the state had a medical marijuana law or not. Mixed results from these studies raise the question of whether this method for measuring policy characteristics is adequate.

Objectives: Our objective was to develop a validated taxonomy of medical marijuana laws that will allow researchers to measure variation in aspects of medical marijuana statutes as well as their overall restrictiveness.

Methods/results: We used a modified Delphi technique using detailed and validated data about each state's medical marijuana law. Three senior researchers coded elements of the state laws in initiation of use, quantity allowed, regulations around distribution, and overall restrictiveness. We used 2013 data from the U.S. National Survey on Drug Use and Health to assess validity of the taxonomy. Results indicate substantial state-level variation in medical marijuana policies. Validation analysis supported the taxonomy's validity for all four dimensions with the largest effect sizes for the quantity allowed in the state's medical marijuana policy.

Conclusions/importance: This analysis demonstrates the potential importance of nondichotomous measurement of medical marijuana laws in studies of their impact. These findings may also be useful to states that are considering medical marijuana laws, to understand the potential impact of characteristics of those laws.

Citing Articles

How do restrictions on opioid prescribing, harm reduction, and treatment coverage policies relate to opioid overdose deaths in the United States in 2013-2020? An application of a new state opioid policy scale.

Doonan S, Wheeler-Martin K, Davis C, Mauro C, Bruzelius E, Crystal S Int J Drug Policy. 2025; 137:104713.

PMID: 39847857 PMC: 11875926. DOI: 10.1016/j.drugpo.2025.104713.


Emerging Health Technologies in Long-Term Care and Suppliers' Views on Their Potential to Assist and Support the Workforce.

Chapman S, Miller J, Spetz J Med Care Res Rev. 2023; 80(6):619-630.

PMID: 37534450 PMC: 10637095. DOI: 10.1177/10775587231190127.


Accuracy Differences in Cannabis Retailer Information Ascertained from Webservices and Government-Maintained State Registries Across US States Legalizing the Sale of Cannabis in 2019.

Williams M, Mahlan M, Holmes C, Pankowska M, Kaur M, Ilegbusi A Cannabis. 2023; 6(2):133-148.

PMID: 37484053 PMC: 10361797. DOI: 10.26828/cannabis/2023/000148.


Recreational cannabis legislation and binge drinking in U.S. adolescents and adults.

Goncalves P, Bruzelius E, Levy N, Segura L, Livne O, Gutkind S Int J Drug Policy. 2023; 118:104085.

PMID: 37329666 PMC: 10527765. DOI: 10.1016/j.drugpo.2023.104085.


PROTOCOL: The effects of cannabis liberalization laws on health, safety, and socioeconomic outcomes: An evidence and gap map.

Sevigny E, Pacula R, Aloe A, Medhin D, Greathouse J Campbell Syst Rev. 2023; 17(1):e1137.

PMID: 37050965 PMC: 8356275. DOI: 10.1002/cl2.1137.


References
1.
Thurstone C, Lieberman S, Schmiege S . Medical marijuana diversion and associated problems in adolescent substance treatment. Drug Alcohol Depend. 2011; 118(2-3):489-92. PMC: 3178678. DOI: 10.1016/j.drugalcdep.2011.03.031. View

2.
Harper S, Strumpf E, Kaufman J . Do medical marijuana laws increase marijuana use? Replication study and extension. Ann Epidemiol. 2012; 22(3):207-12. DOI: 10.1016/j.annepidem.2011.12.002. View

3.
Levy S . Effects of marijuana policy on children and adolescents. JAMA Pediatr. 2013; 167(7):600-2. DOI: 10.1001/jamapediatrics.2013.2270. View

4.
Benac N . US becoming more accepting of medical marijuana. CMAJ. 2013; 185(16):E745-6. PMC: 3826349. DOI: 10.1503/cmaj.109-4612. View

5.
Pedersen E, Miles J, Ewing B, Shih R, Tucker J, DAmico E . A longitudinal examination of alcohol, marijuana, and cigarette perceived norms among middle school adolescents. Drug Alcohol Depend. 2013; 133(2):647-53. PMC: 3836211. DOI: 10.1016/j.drugalcdep.2013.08.008. View